Insider Trading History of Greenstein Ira A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Greenstein Ira A since 2008. The trader's CIK number is 1228161. At the time of the last reporting, Greenstein Ira A was the President of Neubase Therapeutics, Inc.. (stock ticker symbol NBSE). Also see all insider trading activities at Neubase Therapeutics, Inc..

Note that in the past GREENSTEIN IRA A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Idt Corp (IDT,IDT.C) by Greenstein Ira A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 IDT,IDT.C 105,200 $391,824 0 $0 0 $0

Yearly summary of insider trading at Document Security Systems Inc (DMC) by Greenstein Ira A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 DMC 10,000 $15,049 0 $0 0 $0

Yearly summary of insider trading at Neubase Therapeutics, Inc. (OHRP) by Greenstein Ira A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 OHRP 3,500 $33,900 0 $0 0 $0


Insider trading activities at 3 companies by Greenstein Ira A:

1. Idt Corp (IDT,IDT.C)

2. Document Security Systems Inc (DMC)

3. Neubase Therapeutics, Inc. (OHRP)

Table 1. Insider trading of Idt Corp (IDT,IDT.C) by Greenstein Ira A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-03-19 IDT,IDT.C Buy 5,200 3.62 18,824
2008-03-14 IDT,IDT.C Buy 50,000 3.73 186,500
2008-03-14 IDT,IDT.C Buy 50,000 3.73 186,500

Table 2. Insider trading of Document Security Systems Inc (DMC) by Greenstein Ira A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-11-17 DMC Buy 10,000 1.50 15,049

Table 3. Insider trading of Neubase Therapeutics, Inc. (OHRP) by Greenstein Ira A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-07-02 OHRP Buy 1,000 8.40 8,400
2014-04-09 OHRP Buy 2,500 10.20 25,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenstein Ira A (President of Neubase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.